Bioorganic chemistry

current medicinal chemistry

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

BMC infectious diseases

genes

plos neglected tropical diseases

Journal of parasitic diseases : official organ of the Indian Society for Parasitology

iranian journal of parasitology

Acta tropica

Parasites & vectors

Frontiers in cellular and infection microbiology

BMC veterinary research

international journal for parasitology parasites and wildlife

transactions of the royal society of tropical medicine and hygiene

Veterinary dermatology

Practical laboratory medicine

[1] Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform.

[2] Molecular Characterization of Aquaglyceroporine: A Novel Mutation in from (MRHO/IR/75/ER).

[3] Molecular detection and characterization of in free-ranging Egyptian mongoose ().

[4] Surveillance for Leishmania asymptomatic infection in endemic foci of cutaneous leishmaniasis in Venezuela: a combination of leishmanin skin test and PCR using blood clots improves detection and enables identification of species.

[5] Test accuracy of polymerase chain reaction methods against conventional diagnostic techniques for Cutaneous Leishmaniasis (CL) in patients with clinical or epidemiological suspicion of CL: Systematic review and meta-analysis.

[6] Trans-Atlantic Spill Over: Deconstructing the Ecological Adaptation of in the Americas.

[7] Pathogenic Leishmania spp. detected in lizards from Northwest China using molecular methods.

[8] Leishmaniasis diagnosis: an update on the use of parasitological, immunological and molecular methods.

[9] The Potential Role of Nrf2 Signaling in Leishmania Infection Outcomes.

[10] Pathological roles of MRP14 in anemia and splenomegaly during experimental visceral leishmaniasis.

[11] Expression of a rK39 homologue from an Iranian Leishmania infantum isolate in Leishmania tarentolae for serodiagnosis of visceral leishmaniasis.

[12] In vitro assessment of 3-alkoxy-5-nitroindazole-derived ethylamines and related compounds as potential antileishmanial drugs.

[13] alteraÇÕes da matriz extracelular esplÊnica em cÃes naturalmente infectados com leishmania (leishmania) infantum chagasi

[14] gene regulation of pteridine reductase 1 in leishmania promastigotes and amastigotes using a full-length antisense construct

[15] leishmania hijacks myeloid cells for immune escape

[16] evolution of our understanding of myeloid regulatory cells: from mdscs to mregs

[17] comparative study of the biological behaviour in hamster of two isolates of leishmania characterized respectively as l. major-like and l. donovani

[18] in vivo antileishmanial action of ir-(cod)-pentamidine tetraphenylborate on leishmania donovani and leishmania major mouse models

[19] transmission of leishmania in coffee plantations of minas gerais, brazil

[20] definición de las condiciones de temperatura y almacenamiento adecuadas en la detección de adn de leishmania por pcr en flebotominos.

[21] leishmaniose tegumentar americana: estudo clínico, epidemiológico e laboratorial realizado no hospital universitário de campo grande, mato grosso do sul, brasil american cutaneous leishmaniasis: clinical, epidemiological and laboratory studies conducted at a university teaching hospital in campo grande, mato grosso do sul, brazil

[22] alta prevalencia de infección por leishmania (kinetoplastidae: trypanosomatidae) en perros del norte de colombia

[23] cd8+ t cells in leishmania infections: friends or foes?

[24] drug resistance analysis by next generation sequencing in leishmania

[25] the potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases—part iii: in-silico molecular docking investigations

[26] glucantime resistant leishmania promastigotes are sensitive to pentostam

[27] multiple chemical scaffolds inhibit a promising leishmania drug target

[28] laboratory based diagnosis of leishmaniasis in rodents as the reservoir hosts in southern iran, 2012

[29] las células de langerhans en la inmunidad a leishmaniasis.

[30] the influence of early neutrophil-leishmania interactions on the host immune response to infection

[31] photodynamic antimicrobial chemotherapy (pact) for the treatment of malaria, leishmaniasis and trypanosomiasis

[32] american tegumentary leishmaniasis: an uncommon clinical and histopathological presentation leishmaniose tegumentar americana: uma apresentação clínica e histopatológica incomum

[33] Clinical performance of a quantitative pan-genus Real-time PCR assay for diagnosis of cutaneous and visceral leishmaniasis.

[34] Diversity and geographical distribution of Leishmania species and the emergence of Leishmania (Leishmania) infantum and L. (Viannia) panamensis in Central-Western Venezuela.

[35] Cutaneous leishmaniosis due to Leishmania mexicana in a cat treated with cryotherapy.

[36] Amplicon-based next-generation sequencing reveals the co-existence of multiple Leishmania species in patients with visceral leishmaniasis.

[37] Anti-leishmanial and cytotoxic activities of amino acid-triazole hybrids: Synthesis, biological evaluation, molecular docking and in silico physico-chemical properties

[38] Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents.

[39] Insights into the current status of privileged N-heterocycles as antileishmanial agents.

[40] Targeting malaria and leishmaniasis: Synthesis and pharmacological evaluation of novel pyrazole-1,3,4-oxadiazole hybrids. Part II

[41] Flavonoids induce cell death in Leishmania amazonensis: in vitro characterization by flow cytometry and Raman spectroscopy.

[42] Risk of establishment of canine leishmaniasis infection through the import of dogs into South Africa

[43] Antileishmanial and Immunomodulatory Effect of Babassu-Loaded PLGA Microparticles: A Useful Drug Target to Leishmania amazonensis Infection

[44] Visceral and Cutaneous Leishmaniases in a City in Syria and the Effects of the Syrian Conflict.

[45] Effect of isoxazole derivatives of tetrahydrofuran neolignans on intracellular amastigotes of Leishmania (Leishmania) amazonensis: A structure-activity relationship (SAR) comparative study with triazole-neolignan-based compounds.

[46] Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection.

[47] Immunomodulatory effects of chitin microparticles on Leishmania major-infected BALB/c mice.

[48] Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study.

[49] Effectiveness of Single-Dose Liposomal Amphotericin B in Visceral Leishmaniasis in Bihar.

[50] The usefulness of trained field workers in diagnosis of post-kala-Azar dermal leishmaniasis (PKDL) and clinico-epidemiological profile in highly endemic areas of Bihar

[51] Insecticide susceptibility status of Phlebotomus argentipes, a vector of visceral leishmaniasis in different foci in three states of India

[52] Vitamins (A&D) and Isoprenoid (Chenodeoxycholic acid) molecules are accompanied by Th1 immunostimulatory response and therapeutic cure in vivo: possible antileishmanial drugs

[53] Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India.

[54] Leishmaniasis in Northern Morocco: Predominance of Compared to .

[55] In vitro antiprotozoal activity of some medicinal plants against sleeping sickness, Chagas disease and leishmaniasis.

[56] Performance of different serological tests in the diagnosis of natural infection by Leishmania infantum in dogs.

[57] A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries.

[58] Socioeconomic and behavioural risk factors for infection of visceral leishmaniasis gedaref state – Sudan 2015

[59] American cutaneous leishmaniasis in French Guiana: an epidemiological update and study of environmental risk factors.

[60] Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.

[61] Synthesis of cinnamic acid derivatives and leishmanicidal activity against Leishmania braziliensis.

[62] Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform.

[63] Disseminated Autochthonous Dermal Leishmaniasis Caused by (PCM2 Trang) in a Patient from Central Thailand Infected with Human Immunodeficiency Virus.

[64] Silver and gold nanoparticles from tannic acid: Synthesis, characterization and evaluation of antileishmanial and cytotoxic activities

[65] Novel substituted benzothiazole and Imidazo[2,1-b][1,3,4]Thiadiazole derivatives: Synthesis, characterization, molecular docking study, and investigation of their in vitro antileishmanial and antibacterial activities

[66] New Compounds against <i>Leishmania infantum</i> from <i>Eremurus persicus</i>

[67] Prone Regions of Zoonotic Cutaneous Leishmaniasis in Southwest of Iran: Combination of Hierarchical Decision Model (AHP) and GIS.

[68] An epidemiological study of visceral leishmaniasis in North East Ethiopia using serological and leishmanin skin tests.

[69] Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.

[70] New pyrazolopyrimidine derivatives as Leishmania amazonensis arginase inhibitors

[71] Cytotoxicity, In vitro anti-Leishmanial and fingerprint HPLC- photodiode array analysis of the roots of Trillium govanianum.

[72] High resolution melting based method for rapid discriminatory diagnosis of co-infecting Leptomonas seymouri in Leishmania donovani-induced leishmaniasis.

[73] Publisher Correction: Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition (Nature Communications, (2019), 10, 1, (5273), 10.1038/s41467-019-13356-2)

[74] The use of cold atmospheric plasma in pentostam enhancement as Leishmaniasis treatment in vitro

[75] Antileishmanial activity of amides from Piper amalago and synthetic analogs

[76] Emergence of cutaneous leishmaniasis in a border area at south-east of Iran: an epidemiological survey

[77] Silver and gold nanoparticles from tannic acid: synthesis, characterization and evaluation of antileishmanial and cytotoxic activities.

[78] Leishmaniasis in cat shelters: A serological, molecular and entomological study.

[79] Patients' preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study.

[80] Surveillance for Leishmania asymptomatic infection in endemic foci of cutaneous leishmaniasis in Venezuela: a combination of leishmanin skin test and PCR using blood clots improves detection and enables identification of species.

[81] Test accuracy of polymerase chain reaction methods against conventional diagnostic techniques for Cutaneous Leishmaniasis (CL) in patients with clinical or epidemiological suspicion of CL: Systematic review and meta-analysis.

[82] Leishmania sp. detection and blood-feeding behaviour of Sergentomyia minuta collected in the human leishmaniasis focus of southwestern Madrid, Spain (2012-2017).

[83] [Pediatric cutaneous leishmaniasis in Morocco: Clinical and epidemiological features].

[84] Genomes of Leishmania parasites directly sequenced from patients with visceral leishmaniasis in the Indian subcontinent.

[85] [Epidemiology of Cutaneous Leishmaniasis in Algeria through Molecular Characterization].

[86] Isolation and Molecular Typing of from in a Re-Emerging Focus of Leishmaniasis, Northeastern Italy.

[87] Species diversity and molecular insights into phlebotomine sand flies in Sardinia (Italy)-an endemic region for leishmaniasis.

[88] Molecular Analysis of Gene in Non-Healing Clinical Isolates Obtained from Patients with Cutaneous Leishmaniasis from Central of Iran.

[89] Geospatial analysis of tegumentary leishmaniasis in Rio de Janeiro state, Brazil from 2000 to 2015: Species typing and flow of travelers and migrants with leishmaniasis.

[90] Autochthonous canine visceral leishmaniasis cases occur in Paraná state since 2012: isolation and identification of Leishmania infantum.

[91] Serological and molecular investigation of Leishmania spp. infection in cats from an area endemic for canine and human leishmaniasis in Northeast Brazil.

[92] Phylogenetic insights on Leishmania detected in cats as revealed by nucleotide sequence analysis of multiple genetic markers.

[93] Association of Phlebotomus guggisbergi with Leishmania major and Leishmania tropica in a complex transmission setting for cutaneous leishmaniasis in Gilgil, Nakuru county, Kenya.

[94] Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients

[95] Epidemiology of cutaneous leishmaniasis in Algeria by molecular characterization

[96] Spatiotemporal and molecular epidemiology of cutaneous leishmaniasis in Libya

[97] Molecular epidemiology of human cutaneous leishmaniasis in Jericho and its vicinity in Palestine from 1994 to 2015

[98] Molecular epidemiology of imported cases of leishmaniasis in Australia from 2008 to 2014

[99] Molecular epidemiology of cutaneous leishmaniasis and heterogeneity of Leishmania major strains in Iran

[100] Molecular epidemiology for vector research on leishmaniasis

[101] Molecular epidemiology of American tegumentary Leishmaniasis in Panama